Overall rank by patents
#23,105
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 13 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F02M (SUPPLYING COMBUSTION ENGINES IN GENERAL WITH COMBUSTIBLE MIXTURES OR CONSTITUENTS THEREOF).
The verdict
According to USPTO PatentsView, Nostrum ranks #23,105 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R23105 · Foreign Corporation #23,105 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Nocimed, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Nostrum Energy PTE · this assignee
37 score
3D Lighting Innovati… · lowest
7 score
What this shows Nostrum's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Nostrum Energy PTE. Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 66.7% of grants classified under F02M (SUPPLYING COMBUSTION ENGINES IN GENERAL WITH COMBUSTIBLE MIXTURES OR CONSTITUENTS THEREOF). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2022. By volume, Nostrum sits between Nocimed, Inc. and Numab Therapeutics Ag.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NociMed, Inc.
12 patents
NorMedix, Inc.
12 patents
Norell, Inc.
12 patents
Northern Trust Corporation
12 patents
Novatec, Inc.
12 patents
Novelda AS
12 patents
NuLabel Technologies, Inc.
12 patents
Numab Therapeutics AG
12 patents
Nostrum Energy PTE. LTD.
12 patents
What this shows Nostrum holds 12 patents at rank #23,103, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,103 in granted patent volume.
Other assignees with the most granted patents in Nostrum's primary technology class.
Nostrum's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 16.7% |
| 2017 | 2 | 16.7% |
| 2019 | 3 | 25.0% |
| 2021 | 4 | 33.3% |
| 2022 | 1 | 8.3% |
Top 13 of 13 technology areas
Overall rank by patents
#23,105
of 50,000 tracked assignees
36.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.